Close Menu

Angelman syndrome

Spectrum reports that a clinical trial of a gene therapy for Angelman syndrome is on hold.

Researchers identified 34 episignatures that could be used for diagnostic testing and the interpretation of ambiguous genetic test results.

The companies will work together to identify novel biomarkers of the rare genetic disorder Angelman syndrome.

BioArray Briefs: 2009.03.31

Premium

Baylor College of Medicine, Illumina, Aushon Biosystems, SciGene, Invitrogen

Baylor will use the arrays for studying genomic imprinting and its role in developmental diseases.

Quest plans to develop and sell a diagnostic for prostate cancer based on the biomarker.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.